Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000654
Filing Date
2025-03-26
Accepted
2025-03-25 20:12:05
Documents
59
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1899041
2 ex23-1.htm EX-23.1 3666
3 ex31-1.htm EX-31.1 18722
4 ex31-2.htm EX-31.2 18448
5 ex32-1.htm EX-32.1 9323
6 form10-k_002.jpg GRAPHIC 19411
7 form10-k_003.jpg GRAPHIC 72129
8 form10-k_004.jpg GRAPHIC 63899
9 form10-k_005.jpg GRAPHIC 37247
10 form10-k_006.jpg GRAPHIC 91784
11 form10-k_007.jpg GRAPHIC 57054
12 form10-k_008.jpg GRAPHIC 43242
13 form10-k_009.jpg GRAPHIC 71820
14 vi_001.jpg GRAPHIC 130733
  Complete submission text file 0001641172-25-000654.txt   7968449

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE thar-20241231.xsd EX-101.SCH 32774
16 XBRL CALCULATION FILE thar-20241231_cal.xml EX-101.CAL 37845
17 XBRL DEFINITION FILE thar-20241231_def.xml EX-101.DEF 154636
18 XBRL LABEL FILE thar-20241231_lab.xml EX-101.LAB 372128
19 XBRL PRESENTATION FILE thar-20241231_pre.xml EX-101.PRE 285911
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 800781
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41210 | Film No.: 25769784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)